These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 9731867)

  • 1. Cervical screening adjuncts: recent advances.
    Spitzer M
    Am J Obstet Gynecol; 1998 Aug; 179(2):544-56. PubMed ID: 9731867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two-stage cervical cancer screening: an alternative for resource-poor settings.
    Denny L; Kuhn L; Risi L; Richart RM; Pollack A; Lorincz A; Kostecki F; Wright TC
    Am J Obstet Gynecol; 2000 Aug; 183(2):383-8. PubMed ID: 10942474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A decade has passed...the Pap smear and cervical cancer.
    Linder J
    Am J Clin Pathol; 1997 Nov; 108(5):492-8. PubMed ID: 9353086
    [No Abstract]   [Full Text] [Related]  

  • 4. Cervical specimens collected in liquid buffer are suitable for both cytologic screening and ancillary human papillomavirus testing.
    Sherman ME; Schiffman MH; Lorincz AT; Herrero R; Hutchinson ML; Bratti C; Zahniser D; Morales J; Hildesheim A; Helgesen K; Kelly D; Alfaro M; Mena F; Balmaceda I; Mango L; Greenberg M
    Cancer; 1997 Apr; 81(2):89-97. PubMed ID: 9126136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cervical carcinoma in situ undetected by Papanicolaou smear but identified by cervicography. A case report.
    Ferris DG
    J Fam Pract; 1994 Jan; 38(1):74-7. PubMed ID: 8289055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HPV testing in cervical cytology practice: it's all about choice.
    Stoler MH
    Acta Cytol; 2005; 49(2):117-9. PubMed ID: 15839612
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical experience with the thinPrep Imager System.
    Dawson AE
    Acta Cytol; 2006; 50(5):481-2. PubMed ID: 17017431
    [No Abstract]   [Full Text] [Related]  

  • 8. ThinPrep Processor. Clinical trials demonstrate an increased detection rate of abnormal cervical cytologic specimens.
    Wilbur DC; Cibas ES; Merritt S; James LP; Berger BM; Bonfiglio TA
    Am J Clin Pathol; 1994 Feb; 101(2):209-14. PubMed ID: 8116577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colposcopy, cervicography, speculoscopy and endoscopy. International Academy of Cytology Task Force summary. Diagnostic Cytology Towards the 21st Century: An International Expert Conference and Tutorial.
    van Niekerk WA; Dunton CJ; Richart RM; Hilgarth M; Kato H; Kaufman RH; Mango LJ; Nozawa S; Robinowitz M
    Acta Cytol; 1998; 42(1):33-49. PubMed ID: 9479322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results of AutoPap system-assisted and manual cytologic screening. A comparison.
    Wertlake P
    J Reprod Med; 1999 Jan; 44(1):11-7. PubMed ID: 9987733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance of visual inspection with acetic acid and human papillomavirus testing for detection of high-grade cervical lesions in HIV positive and HIV negative Tanzanian women.
    Dartell MA; Rasch V; Iftner T; Kahesa C; Mwaiselage JD; Junge J; Gernow A; Ejlersen SF; Munk C; Kjaer SK
    Int J Cancer; 2014 Aug; 135(4):896-904. PubMed ID: 24391021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of speculoscopy in the evaluation of women with atypical Papanicolaou smears. Improved cost effectiveness by selective colposcopy.
    Massad LS; Lonky NM; Mutch DG; Mann WJ; Blanco JS; Vasilev SA; Finan MA; Scotti RJ
    J Reprod Med; 1993 Mar; 38(3):163-9. PubMed ID: 8387595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AutoPap 300 QC system scoring of cervical smears without "epithelial cell abnormalities".
    Colgan TJ; Bon N; Lee JS; Patten SF
    Acta Cytol; 1997; 41(1):45-9. PubMed ID: 9022725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of cervical collection by the exact touch, the saccomanno single sampler, combined with automated primary screening.
    Cenci M; Vecchione A
    Diagn Cytopathol; 2000 Oct; 23(4):242-4. PubMed ID: 11002364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of human papillomavirus deoxyribonucleic acid in exfoliated cervicovaginal cells as a predictor of cervical neoplasia in a high-risk population.
    Ritter DB; Kadish AS; Vermund SH; Romney SL; Villari D; Burk RD
    Am J Obstet Gynecol; 1988 Dec; 159(6):1517-25. PubMed ID: 2849881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The PAPNET system for quality control of cervical smears: validation and limits.
    Cenci M; Nagar C; Giovagnoli MR; Vecchione A
    Anticancer Res; 1997; 17(6D):4731-4. PubMed ID: 9494597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Epidemiology of HPV infection].
    Boulanger JC; Sevestre H; Bauville E; Ghighi C; Harlicot JP; Gondry J
    Gynecol Obstet Fertil; 2004 Mar; 32(3):218-23. PubMed ID: 15123119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Would monolayers provide more representative samples and improved preparations for cervical screening? Overview and evaluation of systems available.
    McGoogan E; Reith A
    Acta Cytol; 1996; 40(1):107-19. PubMed ID: 8604562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. False-negative results in cervical cytologic studies.
    Gay JD; Donaldson LD; Goellner JR
    Acta Cytol; 1985; 29(6):1043-6. PubMed ID: 3866457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of the CytoRich monolayer preparation system for cervical cytology. A prelude to automated primary screening.
    Takahashi M; Naito M
    Acta Cytol; 1997; 41(6):1785-9. PubMed ID: 9390142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.